Tinea Pedis
7 competing products in clinical development for Tinea Pedis.
Pipeline by Phase
Phase 17
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Naftifine Hydrochloride Gel 2% + Naftin® Gel 2% + Placebo Topical Gel | Sun Pharmaceutical | Phase 1 | Completed | 29 |
| Naftifine Hydrochloride Cream 2% + Naftin® (Naftifine Hydrochloride) Cream 2% + Placebo Topical Cream | Sun Pharmaceutical | Phase 1 | Completed | 29 |
| Butenafine Hydrochloride Cream, 1% + Lotrimin Ultra® + Butenafine Vehicle | Sun Pharmaceutical | Phase 1 | Completed | 29 |
| Naftifine HCl Cream 1% + Naftin® (Naftifine HCl) Cream 1% + Placebo topical cream | Sun Pharmaceutical | Phase 1 | Completed | 29 |
| TA103 + Placebo Control | Sun Pharmaceutical | Phase 1 | Completed | 29 |
| Oxiconazole Nitrate Cream 1% + Oxiconazole Nitrate Cream 1% (Oxistat®) + Placebo | Sun Pharmaceutical | Phase 1 | Completed | 29 |
| Butenafine cream 1% manufactured by Taro + Lotrimin Ultra (butenafine) 1% + Butenafine Vehicle manufactured by Taro | Sun Pharmaceutical | Phase 1 | Completed | 29 |